Recent PRFX News
- PainReform Provides Business Update for the First Quarter of 2024 • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com • GlobeNewswire Inc. • 05/08/2024 12:30:00 PM
- PainReform Announces Closing of $4 Million Public Offering • GlobeNewswire Inc. • 04/18/2024 06:19:23 PM
- PainReform Announces Pricing of $4 Million Public Offering • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 10:25:16 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 03/01/2024 09:34:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 01:09:46 PM
- PainReform Provides Year-End Business Update • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/29/2024 09:37:40 PM
- PainReform to Present at the Microcap Conference in Atlantic City • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:30:32 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 01/12/2024 09:15:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 01:36:41 PM
- PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/27/2023 09:04:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 09:01:41 PM
- PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds • GlobeNewswire Inc. • 12/26/2023 11:00:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/15/2023 09:09:02 PM
- PainReform Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:41:38 PM
- PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File • GlobeNewswire Inc. • 09/11/2023 12:30:00 PM
- PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary • GlobeNewswire Inc. • 09/07/2023 02:00:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM